TIL

Instil Bio, Inc.

A Dallas biotech firm working on a personal kind of cancer immunotherapy: it takes a patient's own immune cells that have already wandered into a tumor, multiplies them into an army in the lab, and infuses them back to hunt down the cancer. Founded in 2018, the company also developed a CoStAR platform meant to give those engineered cells an extra "on" switch when they meet a tumor. Its name plays on "instil" — boosting the body's own natural immune response to fight disease.

CUSIP: 45783C101HealthcareUS1 holder

Ownership Activity Financials Filings

TIL

TIL

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Changes in Registrant's Certifying Accountant

Results of Operations and Financial Condition

Termination of a Material Definitive Agreement

Results of Operations and Financial Condition

Results of Operations and Financial Condition